RYTM

RhythmB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

View Chart

Current thesis

Composite grade B from latest DB weights. Momentum 74.5 / Value 41.1

Posture

Constructive

Lead driver

Momentum

What changed

Momentum remains the lead driver in the composite, 7D delta -17.9.

What can break

Mixed signals. Wait for cleaner trend confirmation.

Momentum

Value

Sentiment

N/A

Setup hits (3d)

0 · Net Neutral

AI TargetsBase - · Bull - · Bear -

Data freshness

Prices

As of 2026-07-18

Fundamentals

As of 2026-07-17 • Vendor: Data Vendor v1

Scores

As of 2026-07-18 • Model: HYBRID_IC_RP

AI Memo

Unavailable: No memo yet

Investment thesis

As of 2026-07-18

Supporting evidence

What

Grade B · Constructive

Confidence Medium · Net Neutral

Target $139.73

Why

Momentum75 · Δ7d -17.9

Value41 · Δ7d -0.1

SentimentN/A · Δ7d -

So what

Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.

Lead driver: Momentum · See technicals

Momentum

40% active weight

Current posture

7d trendSoftening

Δ7d

-17.9

Δ21d

+2.6

Value

60% active weight

Current posture

7d trendFlat

Δ7d

-0.1

Δ21d

0.0

Sentiment

N/A

Coverage pending

No current score

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Why this grade

Composite grade B. Momentum 74.5 / Value 41.1

Fundamentals (TTM)

As of 2026-07-17

Market Cap

$7.31B

Beta

2.01

Shares Out

68.59M

P/E (TTM) · Derived

-34.3

P/S (TTM)

38.99

P/FCF (TTM) · Derived

-58.84

Rev YoY

+83.8%

EPS YoY

+3.6%

Gross Margin

+89.3%

Op Margin

-106.8%

Net Debt

-$145.82M

Current Ratio

4.17

As of 2026-07-18 • Updated nightlySource: Internal modelMethodology